Obeticholic Acid Stocks List
Date | Stock | Title |
---|---|---|
May 29 | GNFT | GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 |
May 29 | GNFT | Genfit: Under The Radar Biotech With Upcoming Catalysts |
Related Industries:
Biotechnology
- Obeticholic Acid
Obeticholic acid (also known as OCA) is a bile acid derivative used to treat primary biliary cholangitis (PBC), a chronic liver disease. It works by binding to and activating the farnesoid X receptor (FXR), a nuclear receptor that helps regulate bile acid production and metabolism. Obeticholic acid is approved by the U.S. Food and Drug Administration (FDA) for the treatment of PBC in adults.
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles